First Mercantile Trust’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

First Mercantile Trust’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,600	Closed	-$282K	–	961
2018 Q3	$282K	Sell	10,600 -2,600	-20%	-$84.9K	0.06%	394
2018 Q2	$499K	Buy	13,200 +4,600	+53%	+$176K	0.1%	253
2018 Q1	$281K	Buy	8,600 +200	+2%	+$8.78K	0.06%	390
2017 Q4	$409K	Buy	8,400 +900	+12%	+$45.5K	0.08%	315
2017 Q3	$405K	Hold	7,500	–	–	0.07%	356
2017 Q2	$421K	Buy	7,500 +3,300	+79%	+$132K	0.08%	335
2017 Q1	$165K	Buy	+4,200	New	+$134K	0.03%	625
2016 Q1	–	Sell	-2,505	Closed	-$129K	–	967
2015 Q4	$129K	Buy	2,505 +375	+18%	+$18.2K	0.01%	758
2015 Q3	$91K	Buy	+2,130	New	+$103K	0.01%	849

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Mercantile Trust's PTLA Position: Q4 2018 in Review

First Mercantile Trust sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 10,600 shares — an estimated $282K sold.

First Mercantile Trust first reported a position in PTLA in Q3 2015 and held it in 9 quarters. The position peaked at $499K in Q2 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

First Mercantile Trust reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
First Mercantile Trust sold 10,600 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $282K.
First Mercantile Trust first reported a position in Portola Pharmaceuticals, Inc. in Q3 2015 and held it in 9 quarters.
First Mercantile Trust's Portola Pharmaceuticals, Inc. position peaked at $499K in Q2 2018.
181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on First Mercantile Trust's 13F filing for Q4 2018, filed 1 Feb 2019.